Ronald K. Knickerbocker

Treatment of Established Postmenopausal Osteoporosis with Raloxifene: A Randomized Trial

Edward G. Lufkin, Michael Whitaker, Thomas Nickélsen et al. · Journal of Bone and Mineral Research · 1998 · 242 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial

Bruce Ettinger, Dennis M. Black, Bruce Mitlak et al. · Obstetrical & Gynecological Survey · 2000 · 168 citations

Medicine, Pharmacology, Pharmacotherapy +17

Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients

David J. Dorer, Ronald K. Knickerbocker, Michele Baccarani et al. · Leukemia Research · 2016 · 159 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Semiparametric Correction for Attenuation

Jungsywan H. Sepanski, Ronald K. Knickerbocker, Raymond J. Carroll · Journal of the American Statistical Association · 1994 · 47 citations

Business, Biostatistics, Econometrics +16

Impact of Dose Intensity of Ponatinib on Selected Adverse Events: Multivariate Analyses from a Pooled Population of Clinical Trial Patients

Ronald K. Knickerbocker, David J. Dorer, Frank G. Haluska et al. · Blood · 2014 · 45 citations

Medicine, Pharmacology, Pharmacotherapy +14